概括
抗生素苏尔佩拉松可以导致维生素K缺乏,导致延长前列血时间 (PT). 在长期使用期间,临床医生应监测凝血功能,并在必要时考虑进行维生素K1或血输血.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 血液学 血液学 血液学
背景情况:
- 苏尔佩拉松是和硫巴克坦的组合,广泛用于细菌感染.
- 苏尔佩拉松的副作用通常包括过敏反应,胃肠道问题和肝脏功能障碍.
- 凝血异常是Sulperazon的罕见但显著的副作用,经常被忽视.
研究的目的:
- 调查Sulperazon诱导凝血异常的潜力.
- 突出监测长期接受Sulperazon治疗的患者凝血功能的重要性.
主要方法:
- 监测前热血素时间 (PT) 和国际正常化比率 (INR).
- 评估维生素K水平和凝血因子活动 (II,VII,IX,X).
- 使用实验室测试,包括D-二聚体和血小板计数.
主要成果:
- 两名接受Sulperazon治疗的患者出现了严重延长的PT和升高的INR.
- 一名患者的维生素K水平降低,维生素K依赖因子的活性降低.
- 切换抗生素和给予维生素K1/血,纠正了第二名患者的延长PT.
结论:
- 苏尔佩拉松是一种第三代脑素,可以对抗维生素K,导致长时间的PT.
- 在延长的Sulperazon治疗期间,密切监测凝血功能至关重要.
- 经验性干预,如改变抗生素或给人维生素K1/血可能是必要的.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Extrinsic and Intrinsic Pathways of Hemostasis
11.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.9K
Venous Thrombosis I: Introduction
334
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
334
Venous Thrombosis III: Interprofessional Care
271
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
271


